➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
McKinsey
McKesson
Harvard Business School
Express Scripts

Last Updated: August 12, 2020

DrugPatentWatch Database Preview

FREAMINE 8.5% Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Freamine 8.5% patents expire, and what generic alternatives are available?

Freamine 8.5% is a drug marketed by B Braun and is included in one NDA.

The generic ingredient in FREAMINE 8.5% is amino acids. There are three hundred and fifty drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the amino acids profile page.

US ANDA Litigation and Generic Entry Outlook for Freamine 8.5%

A generic version of FREAMINE 8.5% was approved as amino acids by B BRAUN on April 13th, 2012.

  Start Trial

Summary for FREAMINE 8.5%
Drug patent expirations by year for FREAMINE 8.5%
Pharmacology for FREAMINE 8.5%
Drug ClassAmino Acid

US Patents and Regulatory Information for FREAMINE 8.5%

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun FREAMINE 8.5% amino acids INJECTABLE;INJECTION 016822-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Mallinckrodt
Express Scripts
Merck
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.